Detalhe da pesquisa
1.
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development.
Br J Cancer
; 128(7): 1391-1399, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759721
2.
Results of the observational prospective RealFLOT study.
BMC Cancer
; 21(1): 1086, 2021 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625033
3.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32164906
4.
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients.
Pharmacogenomics J
; 19(6): 556-563, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723313
5.
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
BMC Cancer
; 19(1): 283, 2019 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30922323
6.
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram.
Oncology
; 95(6): 344-352, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30130791
7.
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Oncologist
; 22(12): 1463-1469, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28860412
8.
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.
BMC Cancer
; 17(1): 408, 2017 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28599628
9.
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
Gastric Cancer
; 20(5): 825-833, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28028664
10.
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough.
Future Oncol
; 13(25): 2265-2275, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28976226
11.
Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcoma.
Anticancer Drugs
; 27(9): 908-13, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27348763
12.
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO).
Tumori
; 110(3): 203-208, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326240
13.
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Oncologist
; 23(2): 272, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29449512
14.
Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study.
J Cancer Res Clin Oncol
; 149(9): 6601-6611, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795195
15.
Negative hyperselection of elderly patients with RAS and BRAF wild-type metastatic colorectal cancer receiving initial panitumumab plus FOLFOX or 5-FU/LV.
Eur J Cancer
; 195: 113396, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37924647
16.
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation.
J Clin Oncol
; 41(34): 5263-5273, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37535876
17.
A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting.
Cancers (Basel)
; 13(11)2021 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34199435
18.
Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer.
Cancer Treat Rev
; 82: 101935, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31821983
19.
5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer.
Clin Cancer Res
; 14(9): 2749-55, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18451241
20.
Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancer.
Cancer Chemother Pharmacol
; 84(5): 1089-1096, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493178